PNV still powering along on the back of a good sales report showing 75% annual sale growth to 12 million for the quarter...! Its a well known stock and was as high as $4. Being a Bio Medical product the sales seem to show it getting the traction it deserves. Sales growth has been slower than expected/hoped but it seems to be making progress now! Should be good for the target of 2.25
